Russian President Vladimir Putin says Russia has become the first country in the world to formally approve the use of the coronavirus vaccine after a trial on humans in less than two months
According to a report by foreign news agency Reuters, this development paves the way for large-scale vaccination of the Russian population, while the final phase of clinical trials to test safety and efficacy is underway.
The pace at which Russia is moving to develop its vaccine demonstrates its determination to win the global race for an effective product, but there are still concerns that national dignity may be placed before science and safety.
Addressing the official meeting, the Russian president said the vaccine was developed by the Gamaliya Institute in Moscow and was safe and had even been given to his daughter.
"I know it works very well, builds strong immunity and I repeat that it has passed all the required tests," he said.
He hoped that the country would soon start mass production of vaccines.
Its approval by the Ministry of Health predicts the start of a large trial involving thousands of people, commonly known as the Phase III trial.
Such trials are usually required for a vaccine to be formally approved.
At a certain rate, people are exposed to the virus in order to see the effect of the vaccine.
Regulators around the world have insisted that safety should not be compromised in the rapid development of the corona virus vaccine, but a recent survey expressed growing public distrust of governments' efforts to develop such a vaccine. Has gone
A source told Reuters last month that Russian health workers would be given the opportunity to voluntarily vaccinate after treating Corona patients.
More than 100 possible vaccines are being developed around the world to try to control the corona virus.
At least four vaccines are in human testing in the final phase, Phase III, according to WHO data.
No comments:
Post a Comment